Ally Bridge Group β Full Portfolio
41 tracked investments Β· listed companies and verified rows first
Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.
BiotechHealthtechMorristown, US
Scott Giacobello(Executive Officer)inBryan Ball(Executive Officer)Dave Lennon(Executive Officer, Director)inDavid Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)
Co-investors3B Future Health FundDecheng CapitalVivo CapitalAvoro VenturesOrbiMed
CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer.
BiotechHealthtechMedical Devices
Co-investorsDecheng CapitalForesite CapitalLongitude CapitalPalm Drive CapitalRA CapitalTCG Crossover+2 more
HealthtechLowell, US
Robert Spignesi(Executive Officer, Director)inStephen H. Delity(Executive Officer, Director)Michael J. Mullen(Executive Officer)
BoardDavid Hirsch(Director)Richard S. Kollender(Director)Fred Cohen(Director)
Co-investorsEndeavour Vision
LightForce develops generative braces using artificial intelligence and 3D printing technology to create individualized orthodontic appliances tailored to each patient.
Advanced ManufacturingAI & Machine LearningHardwareHealthtechMedical DevicesBoston, US
Alfred Griffin, DMD, PhD(Chief Product Officer / Founder)Dr. Lou Shuman, DMD, CAGS(Co-founder)Erica Rogers(Chief Executive Officer)in
Co-investorsKleiner PerkinsAM VenturesDIAMatrixMatter Venture PartnersOmega Venture Partners+2 more
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
BoardBlake Wu(Director)Juan-Pablo Mas(Director)
Co-investorsNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersCatalio Capital Management, LPCitta CapitalLightstone Ventures+4 more
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSV Health InvestorsTenmileAbingworth+2 more
Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis.
HealthtechMedical DevicesMountain View, US
Matt Brokaw(CEO & President)inDerrick Sung(Executive Officer)inMatthew Salkeld(Executive Officer)Irina Ridley(Executive Officer)inAndre Cheng(Executive Officer)inFred Dinger(Executive Officer, Director)in
Co-investorsLaunchCapitalOrbiMedQuesta CapitalTargeted Technology FundsHorizon
BiotechSan Diego, US
Francois Ferre(Director)Magda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)
Co-investorsBioBritVivo CapitalWuXi Healthcare Ventures
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)ANNIE HAZLEHURST(Director)
BoardKEITH CRANDELL(Director)DAVID R. WALT(Director)in
Co-investorsARCH Venture PartnersIllumina VenturesOno Venture Investment, Inc.TCG CrossoverJanus Henderson InvestorsSection 32+3 more
Developer of an FDA-cleared, patch-worn, cuff-less 24-hour ambulatory blood pressure monitoring system for hypertension diagnosis and treatment.
Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.
HealthtechMedical DevicesPleasanton, US
Chris Buchko(Executive Officer)inDouglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)inMark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)
BoardRyan Drant(Director)in
Co-investorsQuesta CapitalJanus Henderson Investors
Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.
BiotechHealthtechMedical DevicesKirkland, US
Frederick A. Stewart(Executive Officer, Director)Rick Wypych(Executive Officer)in
BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)Gerry Brunk(Director)
Co-investorsAPERTURE Venture PartnersLumira VenturesRedbus VenturesClaret Capital PartnersM.H. Carnegie & Co.
Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.
BiotechSan Mateo, US
Gina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)
BoardAbraham Bassan(Director)
Co-investorsNextech InvestRed Tree VentureSamsara BioCapitalJanus Henderson InvestorsPerceptive Xontogeny VentureThird Rock Ventures
Climb is a French wealth management service that combines advisors with technology to grow clients' assets through an open-architecture selection of investment products (life insurance, retirement PER, real estate, private equity, tax-reduction schemes, crypto).
FintechSaaS
Aldric EmiΓ©(CEO)in
Co-investorsKima VenturesRA CapitalREDMILE
BiotechSanta Ana, US
Alex Yeung(Executive Officer, Director)
BoardBernard Fung(Director)Ronald Cheng(Director)David Nikodem(Director)Phil Bendler(Director)Arthur Przybyl(Director)
Co-investorsWI Harper
HealthtechMaple Grove, US
Michael Brenzel(Executive Officer)Paul Buckman(Executive Officer)Kent Lind(Executive Officer)John Feriancek(Executive Officer)Paul Hindrichs(Executive Officer)David Blue(Executive Officer)
Co-investorsBioStar VenturesDeerfield Management CompanySightLine Partners
Elevage Medical appears to be a medical or healthcare company with a team including physicians, board members, and operational staff, though the specific business activities are not detailed on this team page.
Digital HealthHealthtechMedical Devices
Evan Melrose(Chief Executive Officer & Partner)inMichael Wasserman(Chief Operating Officer & Partner)in
Co-investorsPatient Square Capital
Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Lei Stanley Qi(Scientific Founder)inAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)
BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)
Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.
AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US
Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)Lawrence Mandes(Managing Director, New Markets)in
BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)
Co-investorsSofinnova PartnersTeamworthy VenturesThe Colorado Impact FundVTF CapitalCatalyst InvestorsFidelity Investments+5 more
Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.
BiotechHealthtechMedical DevicesRedwood City, US
Doug Godshall(Executive Officer, Director)inSteve Anheier(Executive Officer)in
BoardJonathan Waldstreicher(Executive Officer)Antoine Papiernik(Director)inSeth Harrison(Director)Zack Scott(Director)
Co-investorsNorwest Venture PartnersATPFidelity InvestmentsGilmartin Capital LLCJanus Henderson InvestorsPerceptive Xontogeny Venture+2 more
OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.
Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain
Co-investorsOxford Investment Opportunity Network (OION)Altium CapitalAmgen VenturesDroia VenturesFrazier Healthcare PartnersNovo Holdings+2 more
Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.
AI & Machine LearningBiotechDeep TechHealthtech
Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in
Co-investorsAltium CapitalClavystBioDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom Investment+5 more
Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.
AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US
Aaron Hurst(Founder)in
Co-investorsVoyager CapitalAmed VenturesAscension VenturesBain Capital Life SciencesCatalio Capital ManagementDelos Capital+2 more
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.
HealthtechMedical DevicesTirat Carmel
Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in
Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more
BiotechNew Haven, US
Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)
BoardDaniel Wagner(Director)John Conley(Director)Gregory Ho(Director)
Co-investorsNorthpond Ventures
AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.
AI & Machine LearningEdTechHR TechArlington, US
Andrew Magliozzi(Founder)in
Co-investorsFundersClubMichelson 20MM FoundationNXT VenturesTechstarsFountain Healthcare PartnersGilde Healthcare+3 more
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)Antoine Papiernik(Director)
Co-investorsFountain Healthcare PartnersSofinnova PartnersGilde HealthcareViking Global Investors
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.
BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US
Eric Leuthardt(Director)inLeo Petrossian(Executive Officer, Director)in
BoardYuanwei Tai(Director)Kevin Reilly(Director)Fred Khosravi(Director)Stavros Vizirgianakis(Director)
Co-investorsAmed Ventures
ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's.
BiotechDeep TechHealthtechToronto, CA
Neil Cashman, M.D.(Chief Scientific Officer and Co-founder)EUGENE WILLIAMS(Chairman and Co-Founder)inROBERT GUNDEL(Executive Officer, Director)JANET CLENNETT(Executive Officer)inNeil K. Warma(President and Chief Executive Officer)inELLIOT GOLDSTEIN(Executive Officer, Director)
Quantum Surgical develops Epione, a robotic-assisted percutaneous ablation platform that helps interventional radiologists treat inoperable or difficult early-stage tumors without surgery by guiding needle placement for tumor destruction.
AI & Machine LearningMedical DevicesRoboticsMiami, US
Bertin Nahum(Co-founder & CEO)inChristophe Sibillin(Executive Officer)in
BoardKevin Reilly(Director)Chris Geyen(Director)Frank Yu(Director)Joseph DeVivo(Director)
Co-investorsBpifrance
SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.
CleantechClimate TechRobotics
Co-investorsAera VCRA CapitalT. Rowe Price
Biotechnology company developing therapeutics that target the extracellular matrix in acute and chronic diseases.
BiotechSan Francisco, US
KENNETH N. HORNE(Executive Officer, Director)ALYSSA PANITCH(Director)JOHN PADERI(Director)KATE STUART(Executive Officer)
Co-investorsMitsui Global InvestmentInCube VenturesLilly Ventures
Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODeβ’.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Timothy A. Springer(Co-Founder)Andrew C. Kruse(Director)Alise Reicin(Executive Officer, Director)inDaniel Lochner(Executive Officer)Marc Schwabish(Executive Officer)inPeter McNamara(Executive Officer)in
Co-investorsEcoR1 CapitalVida VenturesClarusPolaris PartnersSoleus Capital
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesGeneral CatalystGeodesic CapitalHuman CapitalKinnevik+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Founder & CEO)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
HealthtechCampbell, US
Michael Buck(Executive Officer, Director)
BoardFarhad Khosravi(Director)Charles Chon(Director)Daniel Davis(Director)John Buckley(Director)
Co-investorsAscension VenturesBain Capital Life SciencesInnovatus Capital Partners
Vida Health delivers personalized, human-centered digital health care addressing both physical and mental health.
Digital HealthHealthtechSaaSSan Francisco, US
Joe Murad(CEO)Mike Rollain
BoardRichard Frank
Co-investorsAspect VenturesCanvas VenturesGeneral AtlanticHLM Venture PartnersOwl CapitalWebb Investment Network+4 more
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)Steve Zadig(Executive Officer, Director)
BoardRichard Feachem(Director)Tom Saunders(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalEssex Woodlands Healthcare PartnersRevelation PartnersMVM Life Science PartnersTrinity Capital
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.


















